Phase I trial of MP 101 in patients with Huntington's disease.
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2017
At a glance
- Drugs MP 101 (Primary)
- Indications Huntington's disease
- Focus Adverse reactions; Pharmacokinetics
- 08 Nov 2017 According to a Mitochon Pharmaceuticals media release, this trial is expected to initiate in 2018.
- 30 May 2016 New trial record
- 17 May 2016 According to Mitochon Pharmaceuticals media release, the company plans to initiate this trial in 2017.